Renal considerations in patients with type 2 diabetes
This promotional module has been initiated, funded and reviewed by Boehringer Ingelheim. The content of this industry-supported learning activity has been generated by Practice Nurse.
Renal impairment frequently co-exists with diabetes.1 As many agents used to control blood glucose are metabolised by the kidneys, reduced renal function has important implications for the choice and dose of oral hypoglycaemic agents.
This module aims to raise awareness of how chronic kidney disease impacts on the management of hyperglycaemia, including the need for dose reduction for many agents used in the management of type 2 diabetes.
On completion of this module, the general practice nurse should:
This module is one of a series of five. Others in the series are:
This resource is provided at an intermediate level. Read the article and answer the self-assessment questions, and reflect on what you have learned.
Complete the resource to obtain a certificate to include in your revalidation portfolio. You should record the time spent on this resource in your CPD log.
1. NICE CG182. Chronic kidney disease in adults: assessment and management, 2014 (updated 2015). https://www.nice.org.uk/Guidance/cg182 [Accessed March 2021]
Job Code: PC-GB-103940
Date of preparation: March 2021
You can sign up here to receive and manage your electronic communications from Boehringer Ingelheim and its agents acting on its behalf, about BI's products, services and events.